Safety Observer

Request complete sample report for free 🙌
June 2023

Safety Observer 201

The ICH E6(R3) draft Guideline on Good Clinical Practice (GCP) has entered the public consultation period.

Released 09-Jun-2023
Pages 39
Subscribe Highlights

Report 201 — Highlights

ICH E6(R3): GCP

The ICH E6(R3) draft Guideline on Good Clinical Practice (GCP) has entered the public consultation period and various authorities including the FDA, the EMA and the MHRA are inviting stakeholders to submit comments.

CIOMS XIII: RWD & RWE

CIOMS has launched a public consultation on the draft report of Working Group XIII, which covers Real-World Data (RWD) and Real-World Evidence (RWE) in Regulatory Decision Making.

FDA & AI

The FDA is calling for comments on a new discussion paper entitled: “Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products”.

FDA: New PMI rule

The FDA has published a Proposed Rule, which would require a new Patient Medication Information (PMI) in replacement of Medication Guides or Patient Package Inserts.

Ethiopia: PV Guideline

The EFDA (Ethiopian Food and Drug Authority) has published the fourth edition of its Pharmacovigilance Guideline, which brings new requirements for MAHs including Local QPPV and PSMF.

Sign up for alerts

Receive alerts and news on pharmacovigilance regulatory requirements every month.

Register today!

Safety Observer

EUR (€)
My account

Social

3-Month Plan

This Plan includes three consecutive reports starting with the next release. The perfect solution to test the value of our service.

Starts at 180 

1-Year Plan

This Plan includes eleven consecutive reports starting with the next release. Includes a double issue for July/August.

Starts at 600 

Stay in the loop

Join over 1,000 Pharmacovigilance professionals and receive our Free Content straight to your mailbox !